Rapid drug susceptibility testing with a molecular beacon assay is associated with earlier diagnosis and treatment of multidrug-resistant tuberculosis in California

To assess the clinical impact of a molecular beacon (MB) assay that detects multidrug-resistant tuberculosis (MDR TB), we retrospectively reviewed records of 127 MDR TB patients with and without MB testing between 2004 and 2007. Use of the MB assay reduced the time to detection and treatment of MDR...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of clinical microbiology Jg. 48; H. 10; S. 3779
Hauptverfasser:	Banerjee, Ritu, Allen, Jennifer, Lin, S-Y Grace, Westenhouse, Janice, Desmond, Ed, Schecter, Gisela F, Scott, Cheryl, Raftery, Ann, Mase, Sundari, Watt, James P, Flood, Jennifer
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	United States 01.10.2010
Schlagworte:	Adult Antitubercular Agents - pharmacology Antitubercular Agents - therapeutic use California Early Diagnosis Female Humans Male Microbial Sensitivity Tests - methods Middle Aged Molecular Diagnostic Techniques - methods Mycobacterium tuberculosis - drug effects Mycobacterium tuberculosis - genetics Mycobacterium tuberculosis - isolation & purification Retrospective Studies Time Factors Tuberculosis, Multidrug-Resistant - diagnosis Tuberculosis, Multidrug-Resistant - microbiology California
ISSN:	1098-660X, 1098-660X
Online-Zugang:	Weitere Angaben
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!